The thalidomide (Contergan) incident: from the late 1950s to the early 1960s, thalidomide was used in racemic form to relieve morning sickness in pregnant women, causing severe limb defects in more than 10,000 infants, which drove global drug regulatory reform and required that the two enantiomers of chiral drugs be evaluated separately.